Author

Kareem Bechnak

Emory UniversityORCID 0000-0002-0594-0400Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Jens WrammertiD· 2 shared Lilin LaiiD· 2 shared Mehul S. SuthariD· 2 shared Nadine RouphaeliD· 2 shared Sanjeev KumariD· 2 shared Sri Edupuganti· 2 shared Alberto Moreno· 1 shared Alberto MorenoiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Jens WrammertORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyJournal of VirologyPeer-reviewedAug 26, 2026

Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses

Sanjeev Kumar, Lilin Lai, Madison Ellis…·Mehul S. Suthar

This study evaluates antibody responses after a KP.2 spike mRNA vaccine dose, showing durable and broadly cross-reactive immunity against multiple SARS-CoV-2 variants, but reduced neutralizing activity against some emerging subvariants.

2 citationstop 2%

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 3, 2024

XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variants

Shilpi Jain, Sanjeev Kumar, Lilin Lai…·Mehul S. Suthar

The paper evaluates the effectiveness of an XBB.1.5 monovalent booster vaccine, showing improved antibody binding and neutralization against SARS-CoV-2 Omicron variants.

DOI 10.1101/2024.02.03.578771

humanproteomics

𝕏 PostBluesky